erythrosine has been researched along with 1-methyl-4-phenylpyridinium in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Das, NP; Moochhala, SM; Sato, T; Shahi, GS; Sunamoto, J | 1 |
| Bennett, JP; Fall, CP | 1 |
| Freed, WJ; Kishikawa, M; Takashima, H; Tsujihata, M | 1 |
| Geng, ZM; Hu, ZW; Wang, H; Wang, SY; Zhao, B | 1 |
4 other study(ies) available for erythrosine and 1-methyl-4-phenylpyridinium
| Article | Year |
|---|---|
Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and its toxic metabolites on the physicochemical property of the liposomal membrane in relation to their cytochrome P-450 inhibition.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Animals; Cytochrome P-450 CYP1A1; Cytochrome P-450 Enzyme Inhibitors; Dimyristoylphosphatidylcholine; Fluoresceins; Fluorescent Dyes; Kinetics; Liposomes; Male; Membrane Fluidity; Mice; Mice, Inbred C57BL; Microsomes, Liver; Oxidoreductases; Pyridinium Compounds; Spectrometry, Fluorescence | 1992 |
Characterization and time course of MPP+ -induced apoptosis in human SH-SY5Y neuroblastoma cells.
Topics: 1-Methyl-4-phenylpyridinium; Apoptosis; Cell Cycle; Cell Membrane; Cell Nucleus; DNA Fragmentation; Dose-Response Relationship, Drug; Electron Transport; Flow Cytometry; Fluoresceins; Humans; Lactic Acid; Membrane Potentials; Microscopy, Electron, Scanning; Mitochondria; NAD(P)H Dehydrogenase (Quinone); Neuroblastoma; Neurons; Reactive Oxygen Species; Rhodamines; Time Factors; Tumor Cells, Cultured | 1999 |
Bromocriptine protects dopaminergic neurons from levodopa-induced toxicity by stimulating D(2)receptors.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Antiparkinson Agents; Antisense Elements (Genetics); Autoreceptors; Bromocriptine; Cell Survival; Cells, Cultured; Dopamine; Dopamine Agents; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Female; Fetus; Fluoresceins; Free Radicals; Gene Expression; Levodopa; Mesencephalon; Nerve Degeneration; Neurons; Neuroprotective Agents; Neurotoxins; Pregnancy; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Sulpiride; Tyrosine 3-Monooxygenase | 1999 |
[Neuroprotective effects of paeonol in a cell model of Parkinson disease].
Topics: 1-Methyl-4-phenylpyridinium; Acetophenones; Animals; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Cell Survival; Down-Regulation; Fluoresceins; Neuroprotective Agents; Parkinson Disease; PC12 Cells; Proto-Oncogene Proteins c-bcl-2; Rats; Reactive Oxygen Species | 2015 |